VenoVision
Getting to the Heart of Hemodynamics.
A Continuous & Non-Contact Monitoring Device
Undetected Patient Deterioration
Undetected hemodynamic deterioration in patients can lead to shock, heart failure, multi-organ dysfunction and death.
This contributes to more than $200Billion of direct hospital costs on more intensive treatments, unplanned ICU admissions and extended lengths of stay from perioperative complications, as well as from related readmissions.
The VenoVision Solution
VenoVision will help reduce all this by providing medical teams with continuous hemodynamic assessment of heart failure patients, those undergoing diuretic or fluid therapy, and general at-risk post-operative patients. Insights previously limited to cardiac catheterizations will be non-invasively captured by our easy-to-use, contactless, thermal imaging monitoring device.
By releasing the right patients earlier, monitoring more complex patients more closely, and making them all more stable, VenoVision can save the hospital up to $50k /patient.
Non-Invasive
The system will enable the monitoring of key indicators, which previously required catheter lines to measure
AI-Driven Vision Analysis
Using proprietary analysis of thermal images, the system can provide patient vital signs that doctors know and trust
Easy to Use
In the hospital, the device will be close to the patient and be non-contact.
In the home, it will be as simple as taking a selfie
Impacting the Continuum of Care
Additional monitoring, prediction and medical alert capabilities will offer telehealth and remote monitoring services a powerful, new level of service
Leadership Team
Prof. Tal Hasin, MD
Head of Heart Failure Unit, Shaare Zedek Medical Center
Prof. Yaakov Nahmias
Director, Grass Center for Bioengineering, The Hebrew University
